Understanding and Addressing Pediatric Asthma Disparities in Black Children

African American children face disproportionately high rates of asthma compared to their peers, experiencing more severe symptoms, higher rates of hospitalization, and increased mortality from the chronic respiratory condition. While environmental factors such as air pollution, housing quality, and urban allergen exposure play significant roles, researchers are increasingly focused on understanding the underlying genetic mechanisms that contribute to these health disparities.

Genetic testing and biotechnology platforms like 23andMe have drawn attention to how ancestry-specific genetic variants influence disease risk and treatment efficacy. Historically, clinical research and genomic databases have lacked diverse participants, leaving significant gaps in medical understanding for populations of African descent. Addressing these disparities requires both inclusive genetic research and targeted clinical approaches that recognize the unique biological and environmental stressors affecting Black youth.

The Push for Diverse Genomic Research

For decades, the underrepresentation of Black individuals in genetic studies has hindered the development of personalized medicine for conditions that heavily impact the African American community. When genomic datasets primarily reflect populations of European ancestry, diagnostic tools and targeted therapies may prove less effective for Black patients.

Expanding diversity in genomic registries is essential for identifying specific gene-environment interactions that trigger pediatric asthma. By mapping variations unique to individuals of African descent, medical researchers can better predict who is at highest risk for severe disease pathways and tailor pharmaceutical interventions accordingly.

HBCUs and the Health Workforce Solution

Closing the health equity gap in pediatric respiratory care requires more than just biological data—it demands a workforce that understands and serves Black communities. Historically Black Colleges and Universities (HBCUs), particularly institutions with medical schools such as Meharry Medical College, Howard University College of Medicine, and Morehouse School of Medicine, are at the forefront of training culturally competent physicians and researchers.

Black clinicians and scientists trained at HBCUs play a critical role in bridging trust between research institutions and African American families. Increasing Black representation in pediatric medicine, pulmonology, and genomic science ensures that clinical trials are ethically designed, diverse cohorts are recruited, and community-level interventions directly address the root causes of asthma disparities. Through combined efforts in genomic discovery and workforce diversification, researchers aim to reduce the burden of asthma on the next generation.